Hyderabad (Telangana) [India], August 14 (ANI): Hyderabad-based pharmaceuticals and biologics firm Biological E. Limited (BE) on Thursday entered into an agreement with Janssen Pharmaceutica NV, part of pharma major Johnson & Johnson, for the creation and enhancement of manufacturing cap
Bengaluru (Karnataka) [India], Aug 10 (ANI/NewsVoir): Bangalore based Atrimed Pharma, a pioneer in developing scientifically-tested plant-based medication, has organised Lecture Series by experts An Hour with an Expert - named "AtrimedX Platform" which will be covered in forthcoming six mont
Mumbai (Maharashtra) [India] Aug 7 (ANI/PRNewswire): Alembic Pharmaceuticals, a Vadodara headquartered company, is a leading manufacturer of pharmaceuticals with three business verticals -International generics (approximately 58 per cent), Domestic branded formulations (approximately 31 per
Mumbai (Maharashtra) [India] Aug 6 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a 400 mg version of oral antiviral FabiFlu®, for the treatment of mild to moderate COVID-19 in India.
Mumbai (Maharashtra) [India], Aug 6 (ANI): Glenmark Pharmaceuticals will introduce a 400 mg version of oral anti-viral FabiFlu for the treatment of mild to moderate Covid-19 in India.
Mumbai (Maharashtra) [India], Aug 3 (ANI): Pharmaceutical and biotechnology major Wockhardt said on Monday it has entered into an agreement with the UK Government to fill-finish Covid-19 vaccines.
New Delhi [India], July 23 (ANI): Apart from the mobile handset sector the Finance Ministry is looking at adding more sectors in production-linked incentive schemes, extending it to medical equipment and pharmaceuticals sectors, said Tarun Bajaj, Secretary, Department of Economic Affairs, Mi
Mumbai (Maharashtra) [India] July 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd - a global research-led pharmaceutical company - announced top-line results from a phase 3 clinical trial in mild to moderate COVID-19 patients, conducted across seven clinical sites in India.
New Delhi [India], July 22 (ANI): Domestic pharma giant Glenmark pharmaceuticals on Thursday announced the positive outcomes from a Phase 3 clinical trial conducted across seven clinical sites in India, where COVID-19 patients administered with Favipiravir reported faster clinical cure an
Hyderabad (Telangana) [India], July 22 (ANI): GMR Hyderabad International Airport has ramped up its cargo capabilities by inducting a unique Multi-ULD (Unit Load Device) Cool Dolly to maintain the unbroken cold chain for time and temperature-sensitive (TSS) shipments such as pharmaceuticals
Mumbai (Maharashtra) [India] July 21 (ANI/PRNewswire): In response to the DCGI letter seeking clarification on FabiFlu, Glenmark Pharmaceuticals Ltd, a research-led, integrated global pharmaceutical company, has responded back. Please click the link below, to access the response letter.
New Delhi [India], July 19 (ANI): The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on COVID-19 patients with comorbidities.